Related references
Note: Only part of the references are listed.Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
Sofia C. Vaz et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
Brane Grambozov et al.
CANCERS (2022)
Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer
Ou Yamaguchi et al.
SCIENTIFIC REPORTS (2022)
Influencing Factors and Prognostic Value of 18F-FDG PET/CT Metabolic and Volumetric Parameters in Non-Small Cell Lung Cancer
Lixia Zhang et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis
Brane Grambozov et al.
THORACIC CANCER (2021)
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions
Chukwuka Eze et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis
Brane Grambozov et al.
CURRENT ONCOLOGY (2021)
Prognostic value of 18F-FDG PET parameters in patients with locally advanced non-small cell lung cancer treated with induction chemotherapy
Hee Yeon Lee et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2020)
Local and regional treatment response by 18FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLC
Judi N. A. van Diessen et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
Ursula Nestle et al.
LANCET ONCOLOGY (2020)
Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer
Kosuke Hashimoto et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study
David Chardin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
18F-Fluorodeoxyglucose PET in Locally Advanced Non-small Cell Lung Cancer From Predicting Outcomes to Guiding Therapy
N. Patrik Brodin et al.
PET CLINICS (2020)
European cancer mortality predictions for the year 2019 with focus on breast cancer
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2019)
Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy
M. Dosani et al.
CURRENT ONCOLOGY (2019)
Re-irradiation in locally recurrent lung cancer patients
Ingmar Schlampp et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2019)
Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma
Daisuke Sano et al.
AURIS NASUS LARYNX (2018)
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer
Alexander L. Chin et al.
CLINICAL LUNG CANCER (2018)
Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits
R. Rulach et al.
CLINICAL ONCOLOGY (2018)
18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study
Sara Carvalho et al.
PLOS ONE (2018)
Serial 4DCT/4DPET imaging to predict and monitor response for locally-advanced non-small cell lung cancer chemo-radiotherapy
Jean-Pierre Bissonnette et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis
Yen-Hao Chen et al.
SCIENTIFIC REPORTS (2018)
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235
Jose G. Bazan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
18F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Nitin Ohri et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy
Maria Vittoria Mattoli et al.
RADIATION ONCOLOGY (2017)
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer
Michael F. Gensheimer et al.
RADIOTHERAPY AND ONCOLOGY (2017)
DART-bid for loco-regionally advanced NSCLC
Karl Wurstbauer et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2017)
Special topics in immunotherapy and radiation therapy: reirradiation and palliation
Tracey Evans et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
Progression and metastasis of lung cancer
Helmut H. Popper
CANCER AND METASTASIS REVIEWS (2016)
Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study
Kiyomi Sumita et al.
RADIATION ONCOLOGY (2016)
The Current and Evolving Role of PET in Personalized Management of Lung Cancer
Esther Mena et al.
PET CLINICS (2016)
PET-Based Thoracic Radiation Oncology
Charles B. Simone et al.
PET CLINICS (2016)
Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer
Seung Hyup Hyun et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2015)
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data
Marianne Paesmans et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancer
Nitin Ohri et al.
LUNG CANCER (2015)
Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis
Hyung-Jun Im et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Primary Tumor Standardized Uptake Value Measured on F18-Fluorodeoxyglucose Positron Emission Tomography Is of Prediction Value for Survival and Local Control in Non-Small-Cell Lung Cancer Receiving Radiotherapy Meta-Analysis
Feifei Na et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer
Dirk De Ruysscher et al.
LANCET ONCOLOGY (2014)
High-dose, conventionally fractionated thoracic reirradiation for lung tumors
Gwendolyn H. M. J. Griffioen et al.
LUNG CANCER (2014)
Heterogeneity in [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Non-Small Cell Lung Carcinoma and Its Relationship to Metabolic Parameters and Pathologic Staging
Ober Van Gomez Lopez et al.
MOLECULAR IMAGING (2014)
18F-FDG PET Early Response Evaluation of Locally Advanced Non-Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy
Edwin A. Usmanij et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)
Marsha Reyngold et al.
RADIATION ONCOLOGY (2013)
Reirradiation and stereotactic radiotherapy for tumors in the lung: Dose summation and toxicity
Thomas R. Meijneke et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer
Hao Zhang et al.
INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY (2013)
Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: A potential modality for inducing long-term survival in selected patients
Takayuki Ohguri et al.
LUNG CANCER (2012)
CHEST REIRRADIATION WITH EXTERNAL BEAM RADIOTHERAPY FOR LOCALLY RECURRENT NON-SMALL-CELL LUNG CANCER: A REVIEW
Branislav Jeremic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
RADIATION DOSE-VOLUME EFFECTS IN THE HEART
Giovanna Gagliardi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy
Cary Dehing-Oberije et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography
D Lardinois et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: A prospective phase I-II clinical trial
KL Wu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Reirradiation for locally recurrent lung cancer previously treated with radiation therapy
Y Okamoto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Share Paper
